Health Encyclopedia

Prolactinoma - males

Definition

Prolactinomas are benign tumors of the pituitary gland that secrete prolactin. This hormone is best known for inducing milk production in women, but it also serves as a regulator of sexual function in men.

Causes, incidence, and risk factors

Prolactinomas are the most common pituitary tumors. Men and women are equally likely to be affected. However, smaller tumors (microadenomas) are more common in women, probably because of earlier detection.

Prolactinomas may occur alone or as part of multiple endocrine tumor syndromes.

Symptoms

Symptoms in men include decreased sex drive, impotence, headache, visual impairment, galactorrhea (secretion of milk, which is uncommon), and symptoms of hypopituitarism (low levels of pituitary function, which result in lowered levels of thyroid or adrenal hormones).

Sexual dysfunction may result from hyperprolactinemia alone or from secondary hypogonadism (low testosterone levels).

Signs and tests

Signs may include visual field defects, gynecomastia (enlarged breasts), galactorrhea, loss of musculature or body hair, and signs of hypothyroidism or hypoadrenalism.

Tests may show:

Elevated prolactin
Low testosterone
Low FSH and LH
MRI or CT scan showing pituitary tumor
Abnormal visual fields

Treatment

Treatment often includes use of dopamine-agonist medications (bromocriptine or cabergoline), which lower levels of prolactin. In severe cases (very large or unresponsive tumors), surgery or radiation may be necessary.

Expectations (prognosis)

Most prolactinomas respond well to medication. However, permanent visual loss or hypopituitarism (lowered function of the pituitary gland) may occur.

Complications

Complications include visual loss and infertility. Some people experience nasal congestion, dizziness with standing, nausea, and fatigue, which may be side effects of dopamine-agonist medications.

Calling your health care provider

Call your health care provider if you have any symptoms of prolactinoma.

Review Date:8/6/2004
Reviewed By:Aniket R. Sidhaye, M.D., Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.